JPS5930716B2 - 抗生物質の製造方法 - Google Patents

抗生物質の製造方法

Info

Publication number
JPS5930716B2
JPS5930716B2 JP48096730A JP9673073A JPS5930716B2 JP S5930716 B2 JPS5930716 B2 JP S5930716B2 JP 48096730 A JP48096730 A JP 48096730A JP 9673073 A JP9673073 A JP 9673073A JP S5930716 B2 JPS5930716 B2 JP S5930716B2
Authority
JP
Japan
Prior art keywords
acid
solution
sodium
ylthiomethyl
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP48096730A
Other languages
English (en)
Japanese (ja)
Other versions
JPS4992091A (enrdf_load_html_response
Inventor
隆之 内藤
潤 奥村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00285764A external-priority patent/US3813376A/en
Priority claimed from US00286792A external-priority patent/US3823141A/en
Priority claimed from US00286630A external-priority patent/US3813390A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of JPS4992091A publication Critical patent/JPS4992091A/ja
Publication of JPS5930716B2 publication Critical patent/JPS5930716B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/657Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
    • C07C49/665Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system
    • C07C49/67Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system having two rings, e.g. tetralones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP48096730A 1972-08-31 1973-08-30 抗生物質の製造方法 Expired JPS5930716B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US285764 1972-08-31
US00285764A US3813376A (en) 1972-08-31 1972-08-31 7-(o-aminomethylphenyl-acetamido)-3-(3-hydroxypyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid
US00286792A US3823141A (en) 1972-09-06 1972-09-06 7-(o-aminomethyl-p-hydroxy-phenylacetamido)-3-(3-hydroxy-pyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid
US286630 1972-09-06
US286792 1972-09-06
US00286630A US3813390A (en) 1972-09-06 1972-09-06 7-(o-aminomethylphenylthioacetamido)-3-(3-hydroxypyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP57047336A Division JPS5932476B2 (ja) 1972-09-06 1982-03-26 抗生物質中間体の製法

Publications (2)

Publication Number Publication Date
JPS4992091A JPS4992091A (enrdf_load_html_response) 1974-09-03
JPS5930716B2 true JPS5930716B2 (ja) 1984-07-28

Family

ID=27403558

Family Applications (1)

Application Number Title Priority Date Filing Date
JP48096730A Expired JPS5930716B2 (ja) 1972-08-31 1973-08-30 抗生物質の製造方法

Country Status (10)

Country Link
JP (1) JPS5930716B2 (enrdf_load_html_response)
AU (1) AU476592B2 (enrdf_load_html_response)
DE (1) DE2344095A1 (enrdf_load_html_response)
DK (1) DK145465C (enrdf_load_html_response)
ES (1) ES418328A1 (enrdf_load_html_response)
FI (1) FI57420C (enrdf_load_html_response)
FR (1) FR2279408A1 (enrdf_load_html_response)
GB (1) GB1412721A (enrdf_load_html_response)
NL (1) NL7312062A (enrdf_load_html_response)
SE (1) SE415980B (enrdf_load_html_response)

Also Published As

Publication number Publication date
DK145465C (da) 1983-04-18
FR2279408B1 (enrdf_load_html_response) 1978-07-28
FI57420C (fi) 1980-08-11
DK145465B (da) 1982-11-22
NL7312062A (enrdf_load_html_response) 1974-03-04
GB1412721A (en) 1975-11-05
ES418328A1 (es) 1976-09-01
AU476592B2 (en) 1976-09-30
FR2279408A1 (fr) 1976-02-20
AU5974273A (en) 1975-03-06
SE415980B (sv) 1980-11-17
FI57420B (fi) 1980-04-30
DE2344095A1 (de) 1974-04-18
JPS4992091A (enrdf_load_html_response) 1974-09-03

Similar Documents

Publication Publication Date Title
FI65623C (fi) Foerfarande foer framstaellning av antibiotiskt aktiv (6r 7r)-3-karbamoyloximetyl-7-(2-(fur-2-yl)-2-metoxiiminoacetamido)-cef-3-em-4-karboxylsyra samt dennas icke-giftiga salter
US4025626A (en) 7-Acyl-3-(ureidoalkyl substituted tetrazolylthiomethyl)-cephalosporins
JPS6150956B2 (enrdf_load_html_response)
US3813376A (en) 7-(o-aminomethylphenyl-acetamido)-3-(3-hydroxypyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid
US3814755A (en) 7-(omikron-aminomethylphenylacetamido)-3-(tetrazolo(4,5-b)pyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid
FI56843C (fi) Foerfarande foer framstaellning av antibakteriella 7-(alfa-amino-p-hydroxifenylacetamido)-3-heterocykliska tiometylcefalosporiner
JPS59231090A (ja) フルオロメチルチオオキサセフアロスポリン
US4018921A (en) Substituted phenylglycylcephalosporins
US4041162A (en) 7-Acyl-3-(sulfoalkyl substituted oxadiazolylthiomethyl) cephalosporins
US3910899A (en) 7-(2-Aminomethylphenyl-acetamido)-3-{8 2-(5-hydroxymethyl-1,3,4-thiadiazolyl)-thiomethyl{9 -3-cephem-4-carboxylic acid
JPH0633281B2 (ja) 新規セファロスポリン化合物及び抗菌剤
US4101656A (en) 7β-Acylamino-3-(alkanesulfonamidoalkyl substituted tetrazolylthiomethyl) cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them
US3953439A (en) Substituted phenylglycylcephalosporins
JPS5930716B2 (ja) 抗生物質の製造方法
JPH0521912B2 (enrdf_load_html_response)
JPS596308B2 (ja) テトラゾ−ルチオ−ル誘導体
US3813391A (en) 7-(beta-(o-aminomethylphenyl)propion-amido)-3-(tetrazolo(4,5-b)pyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid
US4107440A (en) Intermediates for preparing substituted phenylglycylcephalosporins
US3910900A (en) 7-(D-a-hydroxy-2-arylacetamido)-3-(3-hydroxypyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acids
US4058609A (en) 7-Dithioacetamido cephalosporins
JPS6117589A (ja) 新規セフアロスポリン誘導体及びその製造法
US4044047A (en) Intermediates for preparing substituted phenylglycylcephalosporins
US4118491A (en) 7-Acyl-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them
US4171362A (en) 7-Acylamino-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins antibacterial compositions containing them and methods of treating bacterial infections with them
US3823141A (en) 7-(o-aminomethyl-p-hydroxy-phenylacetamido)-3-(3-hydroxy-pyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid